A live cell microfluidics device utilizing phenotypic biomarkers for prostate cancer.

被引：0
|
作者：
Albala, David
Mouraviev, Vladimir
Rieger-Christ, Kimberly M.
Sullivan, Travis B.
Kella, Naveen
Knopf, Kevin B.
Rashid, Hani H.
Manak, Michael S.
Hogan, Brad J.
Dixit, Gauri
Berger, Delaney
Su, Wendell R.
Whitfield, Matthew J.
Varsanik, Jonathan S.
Foroohar, Mani
Zappala, Stephen M.
Chander, Ashok C.
Sant, Grannum R.
机构：
[1] Associated Med Profess New York PLLC, Syracuse, NY USA
[2] Florida Hosp, Orlando, FL USA
[3] Lahey Hosp & Med Ctr, Burlington, MA USA
[4] Urology Pl, San Antonio, TX USA
[5] Calif Pacific Med Ctr, San Francisco, CA USA
[6] Univ Rochester, Med Ctr, Rochester, NY 14642 USA
[7] Cellanyx Diagnost, Beverly, MA USA
[8] Lahey Clin Fdn, Andover Urol, Andover, MA USA
[9] Tufts Univ, Sch Med, Boston, MA 02111 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2016年 / 34卷 / 02期
关键词：
D O I：
10.1200/jco.2016.34.2_suppl.338
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
338
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Distinct Expression of Surface and Genetic Biomarkers in Prostate Cancer Cell Lines
    Su, Chen-Ying
    Huang, Gwo-Che
    Chen, I-Cheng
    Chen, Pei-Yu
    Chen, Yu-Jen
    Fang, Hsu-Wei
    [J]. IN VIVO, 2023, 37 (01): : 242 - 246
  • [42] Cell type-specific analyses for identifying prostate cancer biomarkers
    Nelson P.S.
    Montgomery B.
    [J]. Current Urology Reports, 2006, 7 (1) : 57 - 63
  • [43] Development of new, sensitive assay for circulating tumor cell detection in prostate cancer.
    Melnikova, V. O.
    Davis, D. W.
    Mittelman, D.
    Zhang, Y.
    Holz, G. S.
    Doshi, G. K.
    Cen, P.
    Amato, R. J.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [44] Targeting cell-adaptive mechanisms of drug resistance in lethal prostate cancer.
    Subramaniam, Prem
    Vasciaveo, Alessandro
    Arriaga, Juan
    Kesner, Jordan
    Abate-Shen, Cory
    Califano, Andrea
    [J]. CANCER RESEARCH, 2021, 81 (13)
  • [45] Macrophage tumor cell metabolic interactions induce therapeutic resistance in prostate cancer.
    El-Kenawi, Asmaa
    Viqueira, William Dominguez
    Liu, Min
    Awasthi, Shivanshu
    Dhillon, Jasreman
    Yamoah, Kosj
    Yu, Xiaoqing
    Koomen, John
    Gatenby, Robert
    Ruffell, Brian
    [J]. CANCER RESEARCH, 2021, 81 (13)
  • [46] Cell-free DNA as a biomarker for taxane treatment in advanced prostate cancer.
    Sumanasuriya, Semini
    Seed, George
    Mehra, Niven
    Christova, Rossitza
    Pope, Lorna
    Goodall, Jane
    Flohr, Penelope
    Fowler, Gemma
    Bianchini, Diletta
    Rescigno, Pasquale
    Carreira, Suzanne
    Yuan, Wei
    Mace, Sandrine
    Chadjaa, Mustapha
    De Bono, Johann S.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [47] Ultrahigh affinity Raman probe for targeted live cell imaging of prostate cancer
    Li, Ming
    Banerjee, Sangeeta Ray
    Zheng, Chao
    Pomper, Martin G.
    Barman, Ishan
    [J]. CHEMICAL SCIENCE, 2016, 7 (11) : 6779 - 6785
  • [48] Automation, live-cell imaging, and endpoint cell viability for prostate cancer drug screens
    Lyles, Rolando D. Z.
    Martinez, Maria J.
    Sherman, Benjamin
    Schurer, Stephan
    Burnstein, Kerry L.
    [J]. PLOS ONE, 2023, 18 (10):
  • [49] Live cell detection of intracellular biomarkers maintains cancer stem cells for further experimentation
    Weldon, Don
    Williams, Yuko
    Patel, Amish
    McClellan, Steven
    [J]. CANCER RESEARCH, 2016, 76
  • [50] Feasibility of a novel wrist-worn thermal device for management of vasomotor symptoms in patients with prostate cancer.
    Morgans, Alicia K.
    Billes, Sonja K.
    Vetter, Andrew
    Naghavi, Nader
    Le, Diana
    Smith, Matthew
    Peeke, Pamela
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
12345